Cargando…
Circulating Chromogranin A Is Cleaved Into Vasoregulatory Fragments in Patients With Pancreatic Ductal Adenocarcinoma
Chromogranin A (CgA), a secretory protein released in the blood by the neuroendocrine system, consists of a mixture of full-length molecules and fragments endowed of vasoregulatory activity. The extent and the role of CgA fragmentation were investigated in patients with locally advanced or metastati...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7787052/ https://www.ncbi.nlm.nih.gov/pubmed/33425767 http://dx.doi.org/10.3389/fonc.2020.613582 |
_version_ | 1783632753237950464 |
---|---|
author | Reni, Michele Andreasi, Valentina Gasparri, Anna Maria Dugnani, Erica Colombo, Barbara Macchini, Marina Bianco, Mimma Dallatomasina, Alice Citro, Antonio Assi, Emma Protti, Maria Pia Esposito, Antonio Falconi, Massimo Curnis, Flavio Piemonti, Lorenzo Corti, Angelo |
author_facet | Reni, Michele Andreasi, Valentina Gasparri, Anna Maria Dugnani, Erica Colombo, Barbara Macchini, Marina Bianco, Mimma Dallatomasina, Alice Citro, Antonio Assi, Emma Protti, Maria Pia Esposito, Antonio Falconi, Massimo Curnis, Flavio Piemonti, Lorenzo Corti, Angelo |
author_sort | Reni, Michele |
collection | PubMed |
description | Chromogranin A (CgA), a secretory protein released in the blood by the neuroendocrine system, consists of a mixture of full-length molecules and fragments endowed of vasoregulatory activity. The extent and the role of CgA fragmentation were investigated in patients with locally advanced or metastatic pancreatic ductal adenocarcinoma (PDAC, n=172). Multivariate analysis showed that full-length CgA was associated with better progression free and overall survival, whereas CgA C-terminal fragmentation was associated with worse prognosis. In vitro studies showed that PDAC cells can promote the cleavage of CgA C-terminal region by activating plasminogen to plasmin. Limited digestion of full-length CgA with plasmin abolished its anti-angiogenic activity and generated pro-angiogenic molecules. The fragmentation of CgA C-terminal region was increased also in murine models of PDAC. In these models, the inhibition of CgA fragmentation with aprotinin, an inhibitor of plasmin and other serine proteases, or the blockade of pro-angiogenic fragments with specific antibodies inhibited the growth of PDAC implanted subcutaneously in mice. Finally, administration of full-length CgA to mice bearing orthotopic PDAC reduced tumor perfusion, as measured by contrast-enhanced ultrasound. These findings suggest that PDAC can promote the cleavage of circulating CgA C-terminal region to generate fragments that regulate the tumor vascular biology and that may represent new potential therapeutic targets. |
format | Online Article Text |
id | pubmed-7787052 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-77870522021-01-07 Circulating Chromogranin A Is Cleaved Into Vasoregulatory Fragments in Patients With Pancreatic Ductal Adenocarcinoma Reni, Michele Andreasi, Valentina Gasparri, Anna Maria Dugnani, Erica Colombo, Barbara Macchini, Marina Bianco, Mimma Dallatomasina, Alice Citro, Antonio Assi, Emma Protti, Maria Pia Esposito, Antonio Falconi, Massimo Curnis, Flavio Piemonti, Lorenzo Corti, Angelo Front Oncol Oncology Chromogranin A (CgA), a secretory protein released in the blood by the neuroendocrine system, consists of a mixture of full-length molecules and fragments endowed of vasoregulatory activity. The extent and the role of CgA fragmentation were investigated in patients with locally advanced or metastatic pancreatic ductal adenocarcinoma (PDAC, n=172). Multivariate analysis showed that full-length CgA was associated with better progression free and overall survival, whereas CgA C-terminal fragmentation was associated with worse prognosis. In vitro studies showed that PDAC cells can promote the cleavage of CgA C-terminal region by activating plasminogen to plasmin. Limited digestion of full-length CgA with plasmin abolished its anti-angiogenic activity and generated pro-angiogenic molecules. The fragmentation of CgA C-terminal region was increased also in murine models of PDAC. In these models, the inhibition of CgA fragmentation with aprotinin, an inhibitor of plasmin and other serine proteases, or the blockade of pro-angiogenic fragments with specific antibodies inhibited the growth of PDAC implanted subcutaneously in mice. Finally, administration of full-length CgA to mice bearing orthotopic PDAC reduced tumor perfusion, as measured by contrast-enhanced ultrasound. These findings suggest that PDAC can promote the cleavage of circulating CgA C-terminal region to generate fragments that regulate the tumor vascular biology and that may represent new potential therapeutic targets. Frontiers Media S.A. 2020-12-23 /pmc/articles/PMC7787052/ /pubmed/33425767 http://dx.doi.org/10.3389/fonc.2020.613582 Text en Copyright © 2020 Reni, Andreasi, Gasparri, Dugnani, Colombo, Macchini, Bianco, Dallatomasina, Citro, Assi, Protti, Esposito, Falconi, Curnis, Piemonti and Corti http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Oncology Reni, Michele Andreasi, Valentina Gasparri, Anna Maria Dugnani, Erica Colombo, Barbara Macchini, Marina Bianco, Mimma Dallatomasina, Alice Citro, Antonio Assi, Emma Protti, Maria Pia Esposito, Antonio Falconi, Massimo Curnis, Flavio Piemonti, Lorenzo Corti, Angelo Circulating Chromogranin A Is Cleaved Into Vasoregulatory Fragments in Patients With Pancreatic Ductal Adenocarcinoma |
title | Circulating Chromogranin A Is Cleaved Into Vasoregulatory Fragments in Patients With Pancreatic Ductal Adenocarcinoma |
title_full | Circulating Chromogranin A Is Cleaved Into Vasoregulatory Fragments in Patients With Pancreatic Ductal Adenocarcinoma |
title_fullStr | Circulating Chromogranin A Is Cleaved Into Vasoregulatory Fragments in Patients With Pancreatic Ductal Adenocarcinoma |
title_full_unstemmed | Circulating Chromogranin A Is Cleaved Into Vasoregulatory Fragments in Patients With Pancreatic Ductal Adenocarcinoma |
title_short | Circulating Chromogranin A Is Cleaved Into Vasoregulatory Fragments in Patients With Pancreatic Ductal Adenocarcinoma |
title_sort | circulating chromogranin a is cleaved into vasoregulatory fragments in patients with pancreatic ductal adenocarcinoma |
topic | Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7787052/ https://www.ncbi.nlm.nih.gov/pubmed/33425767 http://dx.doi.org/10.3389/fonc.2020.613582 |
work_keys_str_mv | AT renimichele circulatingchromograninaiscleavedintovasoregulatoryfragmentsinpatientswithpancreaticductaladenocarcinoma AT andreasivalentina circulatingchromograninaiscleavedintovasoregulatoryfragmentsinpatientswithpancreaticductaladenocarcinoma AT gasparriannamaria circulatingchromograninaiscleavedintovasoregulatoryfragmentsinpatientswithpancreaticductaladenocarcinoma AT dugnanierica circulatingchromograninaiscleavedintovasoregulatoryfragmentsinpatientswithpancreaticductaladenocarcinoma AT colombobarbara circulatingchromograninaiscleavedintovasoregulatoryfragmentsinpatientswithpancreaticductaladenocarcinoma AT macchinimarina circulatingchromograninaiscleavedintovasoregulatoryfragmentsinpatientswithpancreaticductaladenocarcinoma AT biancomimma circulatingchromograninaiscleavedintovasoregulatoryfragmentsinpatientswithpancreaticductaladenocarcinoma AT dallatomasinaalice circulatingchromograninaiscleavedintovasoregulatoryfragmentsinpatientswithpancreaticductaladenocarcinoma AT citroantonio circulatingchromograninaiscleavedintovasoregulatoryfragmentsinpatientswithpancreaticductaladenocarcinoma AT assiemma circulatingchromograninaiscleavedintovasoregulatoryfragmentsinpatientswithpancreaticductaladenocarcinoma AT prottimariapia circulatingchromograninaiscleavedintovasoregulatoryfragmentsinpatientswithpancreaticductaladenocarcinoma AT espositoantonio circulatingchromograninaiscleavedintovasoregulatoryfragmentsinpatientswithpancreaticductaladenocarcinoma AT falconimassimo circulatingchromograninaiscleavedintovasoregulatoryfragmentsinpatientswithpancreaticductaladenocarcinoma AT curnisflavio circulatingchromograninaiscleavedintovasoregulatoryfragmentsinpatientswithpancreaticductaladenocarcinoma AT piemontilorenzo circulatingchromograninaiscleavedintovasoregulatoryfragmentsinpatientswithpancreaticductaladenocarcinoma AT cortiangelo circulatingchromograninaiscleavedintovasoregulatoryfragmentsinpatientswithpancreaticductaladenocarcinoma |